Management is executing a major restructuring to improve cost structure and efficiency, targeting an 8%-10% EBIT margin, with most savings from 2027. China operations remain profitable, and CapEx/R&D intensity will stay below 5%.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.